Key Metrics
CiteScore 

1.3
Eigenfactor 

0.001 - 0.005
Impact Factor 

10 - 15
Scite Index 

0.92 5-Year SI

Recommended pre-submission checks
Powered by 

Topics Covered on Clinical and Translational Medicine
Clinical and Translational Medicine Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | JOHN WILEY & SONS LTD |
| Language | English |
| Frequency | Article-by-article |
| Article Processing Charges | USD 3000 |
| Publication Time | 4 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Shanghai Institute of Clinical Bioinformatics |
| Frequency | Article-by-article |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Clinical and Translational Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical and Translational Medicine
SLC7A5 promotes colorectal cancer liver metastasis by reprogramming tryptophan metabolism through the Kyn/XANA\u2012AhR axis and reshaping the immune microenvironment
- 6 Aug 2026
- Clinical and Translational Medicine
Chemokine receptor CCR1 restrains adipose tissue remodelling via cAMP/PKA/CREB signalling and adipocyte\u2012macrophage crosstalk in mice
- 6 Aug 2026
- Clinical and Translational Medicine
The evolving landscape of the Warburg effect in gastric cancer: From molecular mechanisms to targeted therapy
- 5 Aug 2026
- Clinical and Translational Medicine
Correction to \u201cEfficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S\u20101 for neoadjuvant therapy of locally advanced gastric cancer with HER2\u2010overexpressing: Preliminary results of a prospective, single\u2010arm, phase II study\u201d
- 5 Aug 2026
- Clinical and Translational Medicine
SelO\u2010mediated nicotinamide adenine dinucleotide hydrolysis and its implications for metabolic therapies
- 5 Aug 2026
- Clinical and Translational Medicine
Integrating pathological morphologies and molecular profiles for clinical biomarker discovery with unified multimodal embedding
- 5 Aug 2026
- Clinical and Translational Medicine
SLC7A5 promotes colorectal cancer liver metastasis by reprogramming tryptophan metabolism through the Kyn/XANA\u2012AhR axis and reshaping the immune microenvironment
- 6 Aug 2026
- Clinical and Translational Medicine
Chemokine receptor CCR1 restrains adipose tissue remodelling via cAMP/PKA/CREB signalling and adipocyte\u2012macrophage crosstalk in mice
- 6 Aug 2026
- Clinical and Translational Medicine
The evolving landscape of the Warburg effect in gastric cancer: From molecular mechanisms to targeted therapy
- 5 Aug 2026
- Clinical and Translational Medicine
Correction to \u201cEfficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S\u20101 for neoadjuvant therapy of locally advanced gastric cancer with HER2\u2010overexpressing: Preliminary results of a prospective, single\u2010arm, phase II study\u201d
- 5 Aug 2026
- Clinical and Translational Medicine
SelO\u2010mediated nicotinamide adenine dinucleotide hydrolysis and its implications for metabolic therapies
- 5 Aug 2026
- Clinical and Translational Medicine
Integrating pathological morphologies and molecular profiles for clinical biomarker discovery with unified multimodal embedding
- 5 Aug 2026
- Clinical and Translational Medicine